SBIR/STTR Research Award

Novel Polymer Coatings to Prevent Biofilms on Urinary Stents and Catheters

Award identifier cd187ae34cd1f3910062f88d2f554a1a34549305efafcffabb0e06ee49d06d79Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,985

Program and phase

SBIR · Phase I

Award year

2008

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Nerites Corporation
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2007-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Project Summary/Abstract Novel Polymer Coatings to Prevent Biofilms on Urinary Stents and Catheters Nearly all patients with indwelling urinary stents or catheters experience bacterial infections and pro blems with encrustation. For stents, these problems are so common and so severe that stents are replaced at least every six months. Considering that about 100 million urethral catheters and urinary stents are placed in patients each year, millions of devic e-associated infections occur annually. Biofilms formed on the surface of these urinary devices are the source of most infections and encrustations, because pathogenic bacteria thrive within the protective environment biofilms create. Biofilm formation sta rts within minutes of implantation when soluble proteins and other macromolecules from the urine non-specifically adsorb to the device surface. These macromolecules provide an anchor for pathogenic bacteria, which then recruit other bacteria. Eventually a colony of multiple pathogenic bacteria, protected by a slime layer of secreted exopolymers, develops. Many attempts have been made to combat bacterial infection and biofilm formation on urological devices, and have met with varied success. The pr oposed Phase I research is a new approach to prevent biofilm formation on urinary stents and catheters which exploits key components of the adhesive proteins that marine mussels secrete to tether themselves to underwater surfaces. This long-lasting, cost-e ffective approach is non-leaching (i.e. does not release any biocides or antibiotics), biocompatible, simple to process, and easy to apply to urinary device surfaces. The primary objectives of this research are to establish the feasibility of (1) c hemically synthesizing new antifouling polymers that are durable and long-lasting, (2) modifying the surfaces of urinary devices, and (3) preventing biofilm formation under static and dynamic conditions. In this Phase I study, we will establish the proof o f principle that the polymers described above will adsorb to and then inhibit bacterial attachment and encrustation on the types of materials used to manufacture urinary devices. Project Narrative Novel Polymer Coatings to Prevent Biofilms on Uri nary Stents and Catheters Urinary catheters and stents can be life-saving medical devices, but bacterial biofilm growth on the device can cause dangerous infections. Current methods to prevent biofilms are expensive, often ineffective, and can promote antibiotic resistance. Our proposed coating technology will, without antibiotics or biocides, potentially block biofilm formation reliably and inexpensively.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.